000 | 01988 a2200565 4500 | ||
---|---|---|---|
005 | 20250511180532.0 | ||
264 | 0 | _c19921223 | |
008 | 199212s 0 0 eng d | ||
022 | _a0027-8424 | ||
024 | 7 |
_a10.1073/pnas.89.22.11102 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTurka, L A | |
245 | 0 | 0 |
_aT-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. _h[electronic resource] |
260 |
_bProceedings of the National Academy of Sciences of the United States of America _cNov 1992 |
||
300 |
_a11102-5 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies, Monoclonal _ximmunology |
650 | 0 | 4 |
_aAntigens, CD _ximmunology |
650 | 0 | 4 |
_aAntigens, Differentiation, T-Lymphocyte _ximmunology |
650 | 0 | 4 | _aCD28 Antigens |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 | _aGraft Rejection |
650 | 0 | 4 | _aGraft Survival |
650 | 0 | 4 |
_aHeart Transplantation _ximmunology |
650 | 0 | 4 | _aLigands |
650 | 0 | 4 | _aLymphocyte Activation |
650 | 0 | 4 | _aMajor Histocompatibility Complex |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Inbred BN |
650 | 0 | 4 | _aRats, Inbred Lew |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aReceptors, Antigen, T-Cell _ximmunology |
650 | 0 | 4 |
_aReceptors, Cell Surface _ximmunology |
650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
650 | 0 | 4 | _aThymectomy |
650 | 0 | 4 | _aTransplantation, Homologous |
700 | 1 | _aLinsley, P S | |
700 | 1 | _aLin, H | |
700 | 1 | _aBrady, W | |
700 | 1 | _aLeiden, J M | |
700 | 1 | _aWei, R Q | |
700 | 1 | _aGibson, M L | |
700 | 1 | _aZheng, X G | |
700 | 1 | _aMyrdal, S | |
700 | 1 | _aGordon, D | |
773 | 0 |
_tProceedings of the National Academy of Sciences of the United States of America _gvol. 89 _gno. 22 _gp. 11102-5 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1073/pnas.89.22.11102 _zAvailable from publisher's website |
999 |
_c1338594 _d1338594 |